About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Precision Cardiology Market Size & Growth Analysis | 2032
Precision Cardiology Market

Precision Cardiology Market Size, Share & Trends Analysis Report By Offering (Service, Product), By Sample (Blood, Non-Blood, Saliva, Buccal swabs), By Technology (Sequencing, Polymerase Chain Reaction (PCR), Microarray), By Application (Cardiomyopathy, Arrhythmia, Aortopathy and Vascular Diseases, Familial Hypercholesterolemia (FH), Congenital Heart Defects and Syndromes), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institute) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI1989DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Precision Cardiology Market Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Service
        1. By Value
      3. Product
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Blood
        1. By Value
      3. Non-Blood
        1. By Value
      4. Saliva
        1. By Value
      5. Buccal swabs
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing
        1. By Value
        2. Next-generation sequencing (NGS)
          1. Next-generation sequencing (NGS) By Value
        3. Sanger sequencing
          1. Sanger sequencing By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Cardiomyopathy
        1. By Value
      3. Arrhythmia
        1. By Value
      4. Aortopathy and Vascular Diseases
        1. By Value
      5. Familial Hypercholesterolemia (FH)
        1. By Value
      6. Congenital Heart Defects and Syndromes
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Academic and Research Institute
        1. By Value
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Service
        1. By Value
      3. Product
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Blood
        1. By Value
      3. Non-Blood
        1. By Value
      4. Saliva
        1. By Value
      5. Buccal swabs
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing
        1. By Value
        2. Next-generation sequencing (NGS)
          1. Next-generation sequencing (NGS) By Value
        3. Sanger sequencing
          1. Sanger sequencing By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Cardiomyopathy
        1. By Value
      3. Arrhythmia
        1. By Value
      4. Aortopathy and Vascular Diseases
        1. By Value
      5. Familial Hypercholesterolemia (FH)
        1. By Value
      6. Congenital Heart Defects and Syndromes
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Academic and Research Institute
        1. By Value
    7. U.S.
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Service
          1. By Value
        3. Product
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Blood
          1. By Value
        3. Non-Blood
          1. By Value
        4. Saliva
          1. By Value
        5. Buccal swabs
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing
          1. By Value
          2. Next-generation sequencing (NGS)
            1. Next-generation sequencing (NGS) By Value
          3. Sanger sequencing
            1. Sanger sequencing By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Cardiomyopathy
          1. By Value
        3. Arrhythmia
          1. By Value
        4. Aortopathy and Vascular Diseases
          1. By Value
        5. Familial Hypercholesterolemia (FH)
          1. By Value
        6. Congenital Heart Defects and Syndromes
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Academic and Research Institute
          1. By Value
    8. Canada
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Service
        1. By Value
      3. Product
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Blood
        1. By Value
      3. Non-Blood
        1. By Value
      4. Saliva
        1. By Value
      5. Buccal swabs
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing
        1. By Value
        2. Next-generation sequencing (NGS)
          1. Next-generation sequencing (NGS) By Value
        3. Sanger sequencing
          1. Sanger sequencing By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Cardiomyopathy
        1. By Value
      3. Arrhythmia
        1. By Value
      4. Aortopathy and Vascular Diseases
        1. By Value
      5. Familial Hypercholesterolemia (FH)
        1. By Value
      6. Congenital Heart Defects and Syndromes
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Academic and Research Institute
        1. By Value
    7. U.K.
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Service
          1. By Value
        3. Product
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Blood
          1. By Value
        3. Non-Blood
          1. By Value
        4. Saliva
          1. By Value
        5. Buccal swabs
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing
          1. By Value
          2. Next-generation sequencing (NGS)
            1. Next-generation sequencing (NGS) By Value
          3. Sanger sequencing
            1. Sanger sequencing By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Cardiomyopathy
          1. By Value
        3. Arrhythmia
          1. By Value
        4. Aortopathy and Vascular Diseases
          1. By Value
        5. Familial Hypercholesterolemia (FH)
          1. By Value
        6. Congenital Heart Defects and Syndromes
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Academic and Research Institute
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Service
        1. By Value
      3. Product
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Blood
        1. By Value
      3. Non-Blood
        1. By Value
      4. Saliva
        1. By Value
      5. Buccal swabs
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing
        1. By Value
        2. Next-generation sequencing (NGS)
          1. Next-generation sequencing (NGS) By Value
        3. Sanger sequencing
          1. Sanger sequencing By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Cardiomyopathy
        1. By Value
      3. Arrhythmia
        1. By Value
      4. Aortopathy and Vascular Diseases
        1. By Value
      5. Familial Hypercholesterolemia (FH)
        1. By Value
      6. Congenital Heart Defects and Syndromes
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Academic and Research Institute
        1. By Value
    7. China
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Service
          1. By Value
        3. Product
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Blood
          1. By Value
        3. Non-Blood
          1. By Value
        4. Saliva
          1. By Value
        5. Buccal swabs
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing
          1. By Value
          2. Next-generation sequencing (NGS)
            1. Next-generation sequencing (NGS) By Value
          3. Sanger sequencing
            1. Sanger sequencing By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Cardiomyopathy
          1. By Value
        3. Arrhythmia
          1. By Value
        4. Aortopathy and Vascular Diseases
          1. By Value
        5. Familial Hypercholesterolemia (FH)
          1. By Value
        6. Congenital Heart Defects and Syndromes
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Academic and Research Institute
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Service
        1. By Value
      3. Product
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Blood
        1. By Value
      3. Non-Blood
        1. By Value
      4. Saliva
        1. By Value
      5. Buccal swabs
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing
        1. By Value
        2. Next-generation sequencing (NGS)
          1. Next-generation sequencing (NGS) By Value
        3. Sanger sequencing
          1. Sanger sequencing By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Cardiomyopathy
        1. By Value
      3. Arrhythmia
        1. By Value
      4. Aortopathy and Vascular Diseases
        1. By Value
      5. Familial Hypercholesterolemia (FH)
        1. By Value
      6. Congenital Heart Defects and Syndromes
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Academic and Research Institute
        1. By Value
    7. UAE
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Service
          1. By Value
        3. Product
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Blood
          1. By Value
        3. Non-Blood
          1. By Value
        4. Saliva
          1. By Value
        5. Buccal swabs
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing
          1. By Value
          2. Next-generation sequencing (NGS)
            1. Next-generation sequencing (NGS) By Value
          3. Sanger sequencing
            1. Sanger sequencing By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Cardiomyopathy
          1. By Value
        3. Arrhythmia
          1. By Value
        4. Aortopathy and Vascular Diseases
          1. By Value
        5. Familial Hypercholesterolemia (FH)
          1. By Value
        6. Congenital Heart Defects and Syndromes
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Academic and Research Institute
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Offering
      1. Introduction
        1. Offering By Value
      2. Service
        1. By Value
      3. Product
        1. By Value
    3. By Sample
      1. Introduction
        1. Sample By Value
      2. Blood
        1. By Value
      3. Non-Blood
        1. By Value
      4. Saliva
        1. By Value
      5. Buccal swabs
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing
        1. By Value
        2. Next-generation sequencing (NGS)
          1. Next-generation sequencing (NGS) By Value
        3. Sanger sequencing
          1. Sanger sequencing By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Microarray
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Cardiomyopathy
        1. By Value
      3. Arrhythmia
        1. By Value
      4. Aortopathy and Vascular Diseases
        1. By Value
      5. Familial Hypercholesterolemia (FH)
        1. By Value
      6. Congenital Heart Defects and Syndromes
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Diagnostic Laboratories
        1. By Value
      4. Academic and Research Institute
        1. By Value
    7. Brazil
      1. By Offering
        1. Introduction
          1. Offering By Value
        2. Service
          1. By Value
        3. Product
          1. By Value
      2. By Sample
        1. Introduction
          1. Sample By Value
        2. Blood
          1. By Value
        3. Non-Blood
          1. By Value
        4. Saliva
          1. By Value
        5. Buccal swabs
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing
          1. By Value
          2. Next-generation sequencing (NGS)
            1. Next-generation sequencing (NGS) By Value
          3. Sanger sequencing
            1. Sanger sequencing By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Microarray
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Cardiomyopathy
          1. By Value
        3. Arrhythmia
          1. By Value
        4. Aortopathy and Vascular Diseases
          1. By Value
        5. Familial Hypercholesterolemia (FH)
          1. By Value
        6. Congenital Heart Defects and Syndromes
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Diagnostic Laboratories
          1. By Value
        4. Academic and Research Institute
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Precision Cardiology Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. ARUP Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Quest Diagnostics
    3. CENTOGENE N.V.
    4. Eurofins Scientific
    5. GENinCode
    6. Exact Sciences Corporation
    7. Fulgent Genetics Inc.
    8. Illumina Inc.
    9. DNA Genotek Inc.
    10. Thermo Fisher Scientific Inc.
    11. Abbott Laboratories
    12. BioMerieux SA10.13 Becton, Dickinson And Company
    13. Danaher Corporation
    14. QIAGEN N.V
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Precision Farming Market Size The global precision farming market size was valued at USD 12.70 billion in 2024 and is projected to reach from USD 14.18 billion in 2025 to USD 34.11 billion by 2033, growing at a CAGR of11.60%
Buy Now
Global Report
The global precision gearbox market revenue is expected to reach a valuation of USD 4,042 million by 2030 growing at a CAGR of 8% during the forecast period (2022–2030). The Asia-Pacific region is expected to dominate the precision gearbox indu
Buy Now
Global Report
The global precision psychiatry market size was valued at USD 758 million in 2021. It is projected to reach USD 3,210 million by 2030, growing at a CAGR of 17.4% during the forecast period (2022–2030). Precision psychiatry, a new disciplin
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.